Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Aldolase C ELISA Kit (AC3102)
Cat.#: ASET-1691
Specifications
Description Human Aldolase C ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Aldolase C concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.87 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 150-2400 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2403 Human FGF2 ELISA Kit (AC3814) Quantitative inquiry ASET-2313 Human Neuropeptide Y ELISA Kit (AC3724) Quantitative inquiry ASET-2350 Human P2Y12 ELISA Kit (AC3761) Quantitative inquiry ASET-1909 Human Angiogenin ELISA Kit (AC3320) Quantitative inquiry ASET-1635 Mouse CX3CR1 ELISA Kit (AC3046) Quantitative inquiry ASET-1717 Mouse DLL4 ELISA Kit (AC3128) Quantitative inquiry ASET-1670 Human Histidine Decarboxylase ELISA Kit (AC3081) Quantitative inquiry ASET-1542 Human SLUG ELISA Kit (AC2953) Quantitative inquiry ASET-1658 ACTH ELISA Kit (AC3069) Quantitative inquiry ASET-1315 Mouse COMT ELISA Kit (AC2726) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket